Patents by Inventor Imad S. Farrukh

Imad S. Farrukh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
    Patent number: 6187767
    Abstract: The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering a dehydroepiandrosterone (DHEA) derivative as defined herein.
    Type: Grant
    Filed: May 14, 1999
    Date of Patent: February 13, 2001
    Assignees: University of Utah Research Foundation, Pharmadigm, Inc.
    Inventors: Barbara A. Araneo, Raymond A. Daynes, Urszula Orlinska, Imad S. Farrukh
  • Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
    Patent number: 6150348
    Abstract: The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering a dehydroepiandrosterone (DHEA) derivative as defined herein.
    Type: Grant
    Filed: May 14, 1999
    Date of Patent: November 21, 2000
    Assignees: University of Utah Research Foundation, Pharmadigm, Inc.
    Inventors: Barbara A. Araneo, Raymond A. Daynes, Urszula Orlinska, Imad S. Farrukh
  • Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
    Patent number: 5977095
    Abstract: The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (bums), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing, or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering a dehydroepiandrosterone (DHEA) derivative as defined herein.
    Type: Grant
    Filed: June 5, 1997
    Date of Patent: November 2, 1999
    Assignees: University of Utah Research Foundation, Pharmadigm, Inc.
    Inventors: Barbara A. Araneo, Raymond A. Daynes, Urszula Orlinska, Imad S. Farrukh
  • Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
    Patent number: 5846963
    Abstract: The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering dehydroepiandrosterone-3-sulfate (DHEAS).
    Type: Grant
    Filed: August 18, 1995
    Date of Patent: December 8, 1998
    Assignees: University of Utah Research Foundation, Pharmadigm, Inc.
    Inventors: Barbara A. Araneo, Urszula Orlinska, Imad S. Farrukh
  • Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
    Patent number: 5753640
    Abstract: The present invention is related to a method for preventing or reducing the effects of ischemia. The ischemia may be associated with injury or reperfusion injury, such as occurs as a result of infarctions, thermal injury (burns), surgical trauma, accidental trauma, hemorrhagic shock and the like. The invention is also related to methods for preventing or reducing bacterial translocation, adult respiratory distress syndrome, adherence of blood cells and platelets to endothelial cells and pulmonary hypertension. In accordance with the present invention, these conditions are prevented or reduced by administering dehydroepiandrosterone-3-sulfate (DHEAS), DHEA or a DHEA congener.
    Type: Grant
    Filed: December 29, 1995
    Date of Patent: May 19, 1998
    Assignees: University of Utah Research Foundation, Pharmadigm, Inc.
    Inventors: Barbara A. Araneo, Urszula Orlinska, Imad S. Farrukh